Opendata, web and dolomites

BEEOXAL

Treatment against honeybee varroosis based on highly effective application of oxalic acid through sublimation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BEEOXAL project word cloud

Explore the words cloud of the BEEOXAL project. It provides you a very rough idea of what is the project "BEEOXAL" about.

serious    maximising    anti    effectiveness    unlike    solutions    medicament    vast    cloud    sl    mixing    12    negative    beeoxal    safe    device    jobs    ready    beekeepers    resistance    wildlife    backed    33    biodiversity    doses       revenue    96    million    varroosis    network    margin    sagavet    compulsory    ap    2014    provides    beekeeping    spot    combining    efficacy    soluciones    spread    faster    oxalic    ensures    delivering    therapeutic    safely    forecasts    pollination    inside    burns    payback    organic    pellets    either    animal    times    colas    byopic    mono    iacute    seconds    countries    hive    honey    handling    decline    worldwide    residue    cumulative    2020    humans    agriculture    sublimate    none    pest    treatments    international    sme    secure    dosage    16    severe    eight    treatment    197    consists    honeybees    thanks    annual    formulation    x6    dose    honeybee    natural    nature    tablet    outmatches    guarantee    disease    burner    synthetic    population    kit    causing    health    homogeneous    cenavisa    medicaments    generating    spanish    optimal    environment    yearly    acid    2022    agent    sublimates   

Project "BEEOXAL" data sheet

The following table provides information about the project.

Coordinator
SAGAVET SOLUCIONES S.L. 

Organization address
address: C/ BALANCO I BOTER 22, ATICO, PLANTA 2A
city: MATARO BARCELONA
postcode: 8302
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://sagavetsoluciones.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.5. (SOCIETAL CHALLENGES - Climate action, Environment, Resource Efficiency and Raw Materials)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2017-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SAGAVET SOLUCIONES S.L. ES (MATARO BARCELONA) coordinator 50˙000.00

Map

 Project objective

Varroosis is the most serious honeybee disease worldwide, causing €197 million loss yearly in the eight main European beekeeping countries, and severe population decline of this main pollination agent, with strong impact on agriculture and wildlife biodiversity. Negative effects are of such extent that the EU provides specific funding (€33.1 M, 2014-16), to support beekeepers applying compulsory annual anti-varroosis treatments, but current medicaments cannot effectively control varroosis because none, either synthetic of organic, guarantee all the features required for optimal pest control: 1) High efficacy; 2) natural and safe for humans, honeybees and environment; 3) no resistance development; 4) Easy-to-use. BEEOXAL outmatches existing solutions by combining these four features. It consists of a treatment kit with (1) easy-to-use mono-dose pellets and (2) a specifically developed device that burns (sublimates) the tablet so it is spread like a cloud inside the hive. BEEOXAL results from the research and vast field experience of Sagavet Soluciones SL, a Spanish SME delivering animal health solutions. Based on a component already present in honey, oxalic acid, BEEOXAL has an efficacy of 96.8%, a large therapeutic margin thanks to improved spot-on formulation and dosage. Unlike synthetic products, BEEOXAL’s organic nature ensures no residue. The ready-for-use mono-dose pellets do not require mixing or handling, and the burner device to directly sublimate the tablet inside each hive allows a homogeneous distribution of the medicament in 30 seconds (x6 times faster than current treatments). This is crucial since it allows beekeepers to work safely and to avoid under/over doses (secure), maximising overall effectiveness. Backed by its international network (Cenavisa, Byopic), Soluciones Apícolas forecasts €6.8 million cumulative revenue for 2020-2022, and payback of 1 year, while generating 12 new jobs.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BEEOXAL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BEEOXAL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.5.;H2020-EU.2.3.1.)

DUSTCOMB (2018)

A Novel Technology to Reduce Industrial Dust Pollution and to Enable Most Efficient Energy Recovery

Read More  

CleanCoat (2017)

Development of eco-friendly architectural coil coatings for clean buildings and pollution-free air

Read More  

NATEDE (2017)

Nature, Technology and Design

Read More